The effect of early enteral nutrition on hyperthermic intraoperative intraperitoneal chemotherapy-induced mucosal permeability following gastrectomy

Journal of Parenteral and Enteral Nutrition

Volumn 36, Issue 2, 2012, Pages 213-218

  Li, Gang ^a   Gu, Rongmin ^a   Wen, Xu ^a   Wei, Da ^a   Ming, Xuezhi ^a   Chen, Huanqiu ^a  

^a JIANGSU CANCER HOSPITAL   (China)

Author keywords

enteral nutrition; oncology; parenteral nutrition

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; CISPLATIN; CREATININE; FLOXURIDINE; FOLINIC ACID; LACTULOSE; MANNITOL; PROTEIN; UREA;

ADULT; ADVANCED CANCER; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EARLY INTERVENTION; ENTERIC FEEDING; FEMALE; GASTRECTOMY; HUMAN; HYPERTHERMIC INTRAOPERATIVE INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STOMACH CANCER; UREA BLOOD LEVEL;

AGED; ANTINEOPLASTIC AGENTS; ENTERAL NUTRITION; FEMALE; GASTRECTOMY; HOT TEMPERATURE; HUMANS; HYPERTHERMIA, INDUCED; INTESTINAL ABSORPTION; INTESTINAL DISEASES; INTESTINAL MUCOSA; INTESTINE, SMALL; LACTULOSE; MALE; MANNITOL; MIDDLE AGED; PERITONEAL NEOPLASMS; PERMEABILITY; POSTOPERATIVE COMPLICATIONS; STOMACH; STOMACH NEOPLASMS;

EID: 84863234935     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607111414022     Document Type: Article

References (25)

1. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol. 2003 ; 56: 1-9 (Pubitemid 36183309)
2. Ajani JA. Evolving chemotherapy for advanced gastric cancer. Oncologist. 2005 ; 10: 49-58 (Pubitemid 43153809)
3. Meyerhardt JA, Fuchs CS. Adjuvant therapy in gastric cancer: can we prevent recurrences?. Oncology (Williston Park). 2003 ; 17: 714-721
4. Yan TD, Black D, Sugarbaker PH, et al. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol. 2007 ; 14: 2702-2713 (Pubitemid 47460649)
5. Daniele B, Perrone F, Gallo C, et al. Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: A double blind, placebo controlled, randomized trial. Gut. 2001 ; 48: 28-33 (Pubitemid 32042638)
6. Yáñez JA, Teng XW, Roupe KA, Fariss MW, Davies NM. Chemotherapy induced gastrointestinal toxicity in rats: involvement of mitochondrial DNA, gastrointestinal permeability and cyclooxygenase-2. J Pharm Pharm Sci. 2003 ; 6: 308-314 (Pubitemid 38097543)
7. Song D, Shi B, Xue H, et al. Green fluorescent protein labeling Escherichia coli TG1 confirms intestinal bacterial translocation in a rat model of chemotherapy. Curr Microbiol. 2006 ; 52: 69-73 (Pubitemid 43142801)
8. Jiang XH, Li N, Li JS. Intestinal permeability in patients after surgical trauma and effect of enteral nutrition versus parenteral nutrition. World J Gastroenterol. 2003 ; 9: 1878-1880 (Pubitemid 37038154)
9. Brenner B, Shah MA, Karpeh MS, et al. A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine leucovorin in patients with locally advanced gastric cancer. Ann Oncol. 2006 ; 17: 1404-1411 (Pubitemid 44403435)
10. Noh SH, Yoo CH, Chung HC, Roh JK, Shin DW, Min JS. Early postoperative intraperitoneal chemotherapy with mitomycin C, 5-fluorouracil and cisplatin for advanced gastric cancer. Oncology. 2001 ; 60: 24-30 (Pubitemid 32041427)
11. Willems D, Cadranel S, Jacobs W. Measurement of urinary sugars by HPLC in the estimation of intestinal permeability: evaluation in pediatric clinical practice. Clin Chem. 1993 ; 39: 888-890 (Pubitemid 23145685)
12. Ensminger WD, Rosowsky A, Raso V, et al. A clinical-pharmaco-logical evaluation of hepatic arterial infusions of 5-fluoro-2′-deoxyuridine and 5-fluorouracil. Cancer Res. 1978 ; 38: 3784-3792 (Pubitemid 9045207)
13. Kelsen DP, Saltz L, Cohen AM, et al. A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer. Cancer. 1994 ; 74: 2224-2233 (Pubitemid 24322275)
14. Inoue K, Onishi H, Kato Y, et al. Comparison of intraperitoneal continuous infusion of floxuridine and bolus administration in a peritoneal gastric cancer xenograft model. Cancer Chemother Pharmacol. 2004 ; 53: 415-422 (Pubitemid 38553664)
15. Sullivan RD, Miller E. The clinical effects of prolonged intravenous infusion of 5-fluoro-2′-deoxyuridine. Cancer Res. 1965 ; 25: 1025-1033
16. De-Souza DA, Greene LJ. Intestinal permeability and systemic infections in critically ill patients: effect of glutamine. Crit Care Med. 2005 ; 33: 1125-1135 (Pubitemid 40638191)
17. Trvis S, Menzies I. Intestinal permeability: functional assessment and significance. Clin Sci (Lond). 1992 ; 82: 471-488
18. Edwin A, Deitch S. Intestinal permeability increased in burn patients shortly after injury. Surgery. 1990 ; 107: 411-416
19. Yao YC, Chen CL, Wang JD, Zhang YL, Jiang B, Xiong DX. Intestinal permeability of patients with advanced digestive tract malignant tumors. Di Yi Jun Yi Da Xue Xue Bao. 2004 ; 24: 569-571
20. Kohout P, Cerman J, Brátová M, Zadák Z. Small-bowel permeability in patients with cytostatic therapy. Nutrition. 1999 ; 15: 546-549 (Pubitemid 29340032)
21. Li Y, Yu Z, Liu F, Tan L, Wu B, Li J. Oral glutamine ameliorates chemotherapy-induced changes of intestinal permeability and does not interfere with the antitumor effect of chemotherapy in patients with breast cancer: A prospective randomized trial. Tumori. 2006 ; 92: 396-401 (Pubitemid 44861774)
22. Miller RC, Richards M, Baird C, Hall EJ. Interaction of hyperthermia and chemotherapy agents: cell lethality and oncogenic potential. Int J Hyperthermia. 1994 ; 10: 89-99 (Pubitemid 24030725)
23. Hildebrandt B, Wust P, Ahlers O, et al. The cellular and molecular basis of hyperthermia. Crit Rev Oncol-Hematol. 2002 ; 43: 33-56 (Pubitemid 34722786)
24. Lambert GP, Gisolfi CV, Berg DJ, et al. Selected contribution: hyperthermia-induced intestinal permeability and the role of oxidative and nitrosative stress. J Appl Physiol. 2002 ; 92: 1750-1761 (Pubitemid 34670935)
25. Prosser C, Stelwagen K, Cummins R, Guerin P, Gill N, Milne C. Reduction in heat-induced gastrointestinal hyperpermeability in rats by bovine colostrum and goat milk powders. J Appl Physiol. 2004 ; 96: 650-654 (Pubitemid 38140169)